11/14/2024
8:15 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
7:00 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
11:15 PM | Poseida Therapeutics (Filer)
| Form EFFECT | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Poseida Therapeutics (Subject)
| Form SC 13G/A | |
05/14/2024
3:06 PM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2024
11:15 PM | Poseida Therapeutics (Filer)
| Form EFFECT | |
05/01/2024
8:07 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
8:17 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
4:01 PM | Poseida Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/08/2024
3:30 PM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
4:29 PM | Mylet Johanna (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
Poseida Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
3:10 PM | Poseida Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/02/2024
7:51 PM | Gergen Mark J (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
1:08 PM | BlackRock Inc. (Filed by)
Poseida Therapeutics (Subject)
| Form SC 13G | |
01/04/2024
3:01 PM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:02 PM | Gergen Mark J (Reporting)
Poseida Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:03 PM | Poseida Therapeutics (Issuer)
Yarema Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
5:06 AM | Poseida Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free PSTX Stock Alerts